Production (Stage)
Creative Medical Technology Holdings, Inc.
CELZ
$2.16
-$0.02-0.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -- | |||
| Cost of Revenue | 0.00% | -- | |||
| Gross Profit | 0.00% | -- | |||
| SG&A Expenses | -36.23% | 179.40% | |||
| Depreciation & Amortization | 35.40% | -22.87% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.92% | 70.20% | |||
| Operating Income | 11.94% | -69.93% | |||
| Income Before Tax | 11.65% | -78.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.65% | -78.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.65% | -78.26% | |||
| EBIT | 11.94% | -69.93% | |||
| EBITDA | 12.52% | -72.45% | |||
| EPS Basic | 24.04% | -45.74% | |||
| Normalized Basic EPS | 24.04% | -45.75% | |||
| EPS Diluted | 24.04% | -45.74% | |||
| Normalized Diluted EPS | 24.04% | -45.75% | |||
| Average Basic Shares Outstanding | 16.31% | 22.31% | |||
| Average Diluted Shares Outstanding | 16.31% | 22.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||